\u5728\u533b\u7597\u3001\u91d1\u878d\u3001\u79d1\u6280\u7b49\u591a\u4e2a\u9886\u57df\uff0c\u60a8\u53ef\u80fd\u7ecf\u5e38\u4f1a\u9047\u5230\u82f1\u6587\u7f29\u5199”MDR”\uff0c\u90a3\u4e48mdr\u662f\u4ec0\u4e48\u610f\u601d\u5462\uff1f<\/p>\n<\/p>\n
\u7b80\u5355\u6765\u8bf4\uff0cMDR\u662f\u4e00\u4e2a\u591a\u4e49\u8bcd\uff0c\u5b83\u5728\u4e0d\u540c\u8bed\u5883\u4e0b\u4ee3\u8868\u5b8c\u5168\u4e0d\u540c\u7684\u6982\u5ff5\uff0c\u6700\u5e38\u89c1\u7684\u89e3\u91ca\u5305\u62ec\u533b\u7597\u5668\u68b0\u9886\u57df\u7684\u201c\u533b\u7597\u5668\u68b0\u6cd5\u89c4\u201d\uff08Medical Device Regulation\uff09\u3001\u91d1\u878d\u9886\u57df\u7684\u201c\u5e02\u573a\u6570\u636e\u89c4\u5219\u201d\uff08Market Data Rules\uff09\u4ee5\u53ca\u5fae\u751f\u7269\u5b66\u4e2d\u7684\u201c\u591a\u91cd\u8010\u836f\u6027\u201d\uff08Multidrug Resistance\uff09\u3002<\/p>\n<\/p>\n
\u4e00\u3001MDR\u7684\u6838\u5fc3\u542b\u4e49\u89e3\u6790<\/strong><\/p>\n \u8981\u51c6\u786e\u7406\u89e3mdr\u662f\u4ec0\u4e48\u610f\u601d\uff0c\u5fc5\u987b\u7ed3\u5408\u5176\u4f7f\u7528\u7684\u5177\u4f53\u9886\u57df\u3002<\/p>\n<\/p>\n 1. \u533b\u7597\u5668\u68b0\u9886\u57df\u7684MDR\uff08Medical Device Regulation\uff09<\/strong><\/p>\n \u5728\u533b\u7597\u5065\u5eb7\u884c\u4e1a\uff0c\u5c24\u5176\u662f\u5728\u6b27\u6d32\u5e02\u573a\uff0cMDR\u6700\u5e38\u6307\u4ee3\u6b27\u76df\u300a\u533b\u7597\u5668\u68b0\u6cd5\u89c4\u300b\u3002<\/p>\n<\/p>\n \u8fd9\u662f\u4e00\u90e8\u53d6\u4ee3\u539f\u6709\u533b\u7597\u5668\u68b0\u6307\u4ee4\uff08MDD\uff09\u7684\u5168\u65b0\u6cd5\u89c4\uff0c\u5176\u6b63\u5f0f\u540d\u79f0\u4e3a\u6b27\u76df2017\/745\u53f7\u6cd5\u89c4\uff0c\u4e8e2017\u5e74\u53d1\u5e03\uff0c\u5e76\u4e8e2021\u5e745\u6708\u6b63\u5f0f\u751f\u6548\u5b9e\u65bd\u3002<\/p>\n<\/p>\n \u8be5\u6cd5\u89c4\u65e8\u5728\u5efa\u7acb\u4e00\u500b\u66f4\u73b0\u4ee3\u3001\u66f4\u4e25\u683c\u3001\u66f4\u900f\u660e\u7684\u533b\u7597\u5668\u68b0\u76d1\u7ba1\u6846\u67b6\uff0c\u786e\u4fdd\u6295\u653e\u5230\u6b27\u76df\u5e02\u573a\u7684\u533b\u7597\u5668\u68b0\u5177\u6709\u66f4\u9ad8\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u6807\u51c6\u3002<\/p>\n<\/p>\n \u5b83\u5bf9\u533b\u7597\u5668\u68b0\u7684\u6574\u4e2a\u751f\u547d\u5468\u671f\uff0c\u4ece\u8bbe\u8ba1\u548c\u751f\u4ea7\u5230\u4e34\u5e8a\u8bc4\u4f30\u3001\u4e0a\u5e02\u540e\u76d1\u7763\u548c\u62a5\u5e9f\uff0c\u90fd\u63d0\u51fa\u4e86\u66f4\u8be6\u5c3d\u7684\u8981\u6c42\u3002<\/p>\n<\/p>\n 2. \u91d1\u878d\u9886\u57df\u7684MDR\uff08Market Data Rules\uff09<\/strong><\/p>\n \u5982\u679c\u60a8\u5728\u91d1\u878d\u6216\u8bc1\u5238\u884c\u4e1a\u5de5\u4f5c\uff0c\u90a3\u4e48MDR\u53ef\u80fd\u4ee3\u8868\u201c\u5e02\u573a\u6570\u636e\u89c4\u5219\u201d\u3002<\/p>\n<\/p>\n \u8fd9\u662f\u7531\u91d1\u878d\u76d1\u7ba1\u673a\u6784\u6216\u4ea4\u6613\u6240\u5236\u5b9a\u7684\u4e00\u5957\u89c4\u5219\uff0c\u7528\u4e8e\u7ba1\u7406\u5e02\u573a\u6570\u636e\u7684\u5206\u53d1\u3001\u4f7f\u7528\u548c\u6536\u8d39\u3002<\/p>\n<\/p>\n \u5b83\u89c4\u5b9a\u4e86\u54ea\u4e9b\u673a\u6784\u53ef\u4ee5\u63a5\u6536\u5b9e\u65f6\u884c\u60c5\u6570\u636e\uff0c\u6570\u636e\u5982\u4f55\u88ab\u6388\u6743\u4f7f\u7528\uff0c\u4ee5\u53ca\u76f8\u5173\u7684\u8d39\u7528\u7ed3\u6784\uff0c\u65e8\u5728\u786e\u4fdd\u5e02\u573a\u6570\u636e\u7684\u516c\u5e73\u3001\u900f\u660e\u548c\u9ad8\u6548\u4f20\u64ad\u3002<\/p>\n<\/p>\n 3. \u5fae\u751f\u7269\u5b66\u4e0e\u533b\u5b66\u9886\u57df\u7684MDR\uff08Multidrug Resistance\uff09<\/strong><\/p>\n \u5728\u516c\u5171\u536b\u751f\u548c\u4e34\u5e8a\u533b\u5b66\u4e2d\uff0cMDR\u662f\u4e00\u4e2a\u81f3\u5173\u91cd\u8981\u7684\u672f\u8bed\uff0c\u610f\u4e3a\u201c\u591a\u91cd\u8010\u836f\u6027\u201d\u3002<\/p>\n<\/p>\n \u5b83\u6307\u7684\u662f\u7ec6\u83cc\u3001\u75c5\u6bd2\u3001\u771f\u83cc\u6216\u5bc4\u751f\u866b\u7b49\u5fae\u751f\u7269\u5bf9\u591a\u79cd\u4e0d\u540c\u79cd\u7c7b\u7684\u6297\u83cc\u836f\u7269\u540c\u65f6\u4ea7\u751f\u8010\u836f\u6027\u7684\u73b0\u8c61\u3002<\/p>\n<\/p>\n \u4f8b\u5982\uff0c\u201cMDR-TB\u201d\u5c31\u662f\u6307\u5bf9\u81f3\u5c11\u4e24\u79cd\u4e00\u7ebf\u6297\u7ed3\u6838\u836f\u7269\u5177\u6709\u8010\u836f\u6027\u7684\u7ed3\u6838\u75c5\uff0c\u8fd9\u7c7b\u611f\u67d3\u7684\u6cbb\u7597\u96be\u5ea6\u6781\u5927\uff0c\u662f\u5168\u7403\u516c\u5171\u536b\u751f\u9762\u4e34\u7684\u4e25\u5cfb\u6311\u6218\u3002<\/p>\n<\/p>\n \u4e8c\u3001\u5176\u4ed6\u53ef\u80fd\u7684MDR\u542b\u4e49<\/strong><\/p>\n \u9664\u4e86\u4e0a\u8ff0\u4e09\u4e2a\u4e3b\u8981\u542b\u4e49\u5916\uff0cMDR\u5728\u5176\u4ed6\u5c0f\u4f17\u6216\u7279\u5b9a\u9886\u57df\u4e5f\u53ef\u80fd\u6709\u5176\u4ed6\u89e3\u91ca\u3002<\/p>\n<\/p>\n \u5728\u4fe1\u606f\u6280\u672f\u9886\u57df\uff0cMDR\u53ef\u80fd\u6307\u201c\u6258\u7ba1\u68c0\u6d4b\u4e0e\u54cd\u5e94\u201d\uff08Managed Detection and Response\uff09\uff0c\u8fd9\u662f\u4e00\u79cd\u9ad8\u7ea7\u7f51\u7edc\u5b89\u5168\u670d\u52a1\uff0c\u63d0\u4f9b\u5546\u901a\u8fc7\u6280\u672f\u624b\u6bb5\u6301\u7eed\u76d1\u63a7\u548c\u5e94\u5bf9\u7f51\u7edc\u5a01\u80c1\u3002<\/p>\n<\/p>\n \u5728\u5546\u4e1a\u673a\u6784\u4e2d\uff0cMDR\u4e5f\u53ef\u80fd\u662f\u67d0\u4e2a\u90e8\u95e8\u6216\u804c\u4f4d\u540d\u79f0\u7684\u7f29\u5199\uff0c\u4f8b\u5982\u201cMedical Department Representative\u201d\uff08\u533b\u5b66\u90e8\u95e8\u4ee3\u8868\uff09\u3002<\/p>\n<\/p>\n \u56e0\u6b64\uff0c\u8131\u79bb\u5177\u4f53\u8bed\u5883\u5b64\u7acb\u5730\u95ee\u201cmdr\u662f\u4ec0\u4e48\u610f\u601d\u201d\u5f88\u96be\u5f97\u5230\u552f\u4e00\u7b54\u6848\uff0c\u5173\u952e\u8981\u770b\u5b83\u51fa\u73b0\u5728\u4ec0\u4e48\u6837\u7684\u6587\u4ef6\u548c\u8ba8\u8bba\u4e2d\u3002<\/p>\n<\/p>\n \u4e09\u3001\u5982\u4f55\u533a\u5206\u4e0d\u540c\u8bed\u5883\u4e0b\u7684MDR<\/strong><\/p>\n \u8981\u51c6\u786e\u5224\u65adMDR\u7684\u5177\u4f53\u542b\u4e49\uff0c\u53ef\u4ee5\u901a\u8fc7\u4ee5\u4e0b\u51e0\u4e2a\u6b65\u9aa4\u8fdb\u884c\u533a\u5206\u3002<\/p>\n<\/p>\n \u9996\u5148\uff0c\u89c2\u5bdf\u4e0a\u4e0b\u6587\u662f\u6700\u76f4\u63a5\u7684\u65b9\u6cd5\uff0c\u5982\u679c\u6587\u6863\u6216\u5bf9\u8bdd\u56f4\u7ed5\u533b\u7597\u5668\u68b0\u3001\u6b27\u76df\u6cd5\u5f8b\u3001CE\u8ba4\u8bc1\u7b49\u8bdd\u9898\uff0c\u90a3\u4e48\u5b83\u6781\u6709\u53ef\u80fd\u6307\u7684\u662f\u300a\u533b\u7597\u5668\u68b0\u6cd5\u89c4\u300b\u3002<\/p>\n<\/p>\n \u5176\u6b21\uff0c\u67e5\u770b\u4fe1\u606f\u6765\u6e90\uff0c\u6765\u81ea\u91d1\u878d\u4ea4\u6613\u6240\u6216\u6570\u636e\u4f9b\u5e94\u5546\u7684\u901a\u77e5\u901a\u5e38\u6d89\u53ca\u201c\u5e02\u573a\u6570\u636e\u89c4\u5219\u201d\uff0c\u800c\u533b\u5b66\u671f\u520a\u6216\u533b\u9662\u62a5\u544a\u4e2d\u7684MDR\u5219\u5f88\u53ef\u80fd\u5173\u4e4e\u201c\u591a\u91cd\u8010\u836f\u6027\u201d\u3002<\/p>\n<\/p>\n \u6700\u540e\uff0c\u5f53\u542b\u4e49\u4ecd\u7136\u6a21\u7cca\u65f6\uff0c\u76f4\u63a5\u8be2\u95ee\u5bf9\u65b9\u6216\u67e5\u9605\u4e13\u4e1a\u9886\u57df\u7684\u672f\u8bed\u8bcd\u5178\u662f\u6700\u7a33\u59a5\u7684\u65b9\u5f0f\uff0c\u907f\u514d\u56e0\u8bef\u89e3\u7f29\u5199\u800c\u9020\u6210\u4e0d\u5fc5\u8981\u7684\u9ebb\u70e6\u3002<\/p>\n<\/p>\n \u56db\u3001\u603b\u7ed3<\/strong><\/p>\n \u603b\u800c\u8a00\u4e4b\uff0cmdr\u662f\u4ec0\u4e48\u610f\u601d\u5e76\u6ca1\u6709\u4e00\u4e2a\u56fa\u5b9a\u7684\u7b54\u6848\uff0c\u5b83\u662f\u4e00\u4e2a\u9ad8\u5ea6\u4f9d\u8d56\u8bed\u5883\u7684\u7f29\u5199\u8bcd\u3002<\/p>\n<\/p>\n \u5728\u6b27\u76df\u533b\u7597\u5668\u68b0\u9886\u57df\uff0c\u5b83\u662f\u76d1\u7ba1\u5b89\u5168\u7684\u57fa\u77f3\uff1b\u5728\u5168\u7403\u91d1\u878d\u5e02\u573a\uff0c\u5b83\u662f\u6570\u636e\u4ea4\u6613\u7684\u89c4\u5219\uff1b\u800c\u5728\u5bf9\u6297\u75be\u75c5\u7684\u6218\u573a\u4e0a\uff0c\u5b83\u5219\u4ee3\u8868\u7740\u68d8\u624b\u7684\u6cbb\u7597\u96be\u9898\u3002<\/p>\n<\/p>\n \u7406\u89e3\u5176\u591a\u91cd\u542b\u4e49\u6709\u52a9\u4e8e\u6211\u4eec\u66f4\u51c6\u786e\u5730\u8fdb\u884c\u4e13\u4e1a\u4ea4\u6d41\u548c\u77e5\u8bc6\u83b7\u53d6\uff0c\u5e0c\u671b\u672c\u6587\u80fd\u5e2e\u52a9\u60a8\u6e05\u6670\u5730\u8fa8\u522b\u4e0d\u540c\u573a\u666f\u4e0b\u7684MDR\uff0c\u4ece\u800c\u66f4\u6709\u6548\u5730\u5e94\u7528\u8fd9\u4e00\u672f\u8bed\u3002<\/p>\n<\/p>\n \u514d\u8d23\u58f0\u660e\uff1a\u4ec5\u4f9b\u53c2\u8003\uff0c\u672c\u6587\u4f5c\u8005\u53ca\u53d1\u5e03\u5e73\u53f0\u4e0d\u627f\u62c5\u56e0\u53c2\u8003\u672c\u6587\u5185\u5bb9\u800c\u4ea7\u751f\u7684\u4efb\u4f55\u8d23\u4efb<\/p>\n","protected":false},"excerpt":{"rendered":" \u5728\u533b\u7597\u3001\u91d1\u878d\u3001\u79d1\u6280\u7b49\u591a\u4e2a\u9886\u57df\uff0c\u60a8\u53ef\u80fd\u7ecf\u5e38\u4f1a\u9047\u5230\u82f1\u6587\u7f29\u5199”MDR”\uff0c\u90a3\u4e48mdr\u662f\u4ec0\u4e48\u610f\u601d […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[226],"class_list":["post-3919","post","type-post","status-publish","format-standard","hentry","category-uncategorized","tag-mdr"],"_links":{"self":[{"href":"https:\/\/rohs.ac.cn\/index.php?rest_route=\/wp\/v2\/posts\/3919","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rohs.ac.cn\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rohs.ac.cn\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rohs.ac.cn\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/rohs.ac.cn\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3919"}],"version-history":[{"count":0,"href":"https:\/\/rohs.ac.cn\/index.php?rest_route=\/wp\/v2\/posts\/3919\/revisions"}],"wp:attachment":[{"href":"https:\/\/rohs.ac.cn\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3919"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rohs.ac.cn\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3919"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rohs.ac.cn\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3919"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}